Lipidor announces positive results from Phase I/IIa psoriasis study

Drug delivery company Lipidor, 50% owned by Karolinska Development, has reported positive results from Phase I/IIa psoriasis study of Akvano/calcipotriol spray formulation, a water-free spray formulation containing vitamin D derivative calcipotriol.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news